Literature DB >> 21052703

Fetal loss associated with second trimester amniocentesis.

Somsri Pitukkijronnakorn1, Patama Promsonthi, Panyu Panburana, Umaporn Udomsubpayakul, Apichart Chittacharoen.   

Abstract

OBJECTIVE: To evaluate the fetal loss rate associated with second trimester amniocentesis.
METHODS: All cases of pregnant women ≥35 years old with gestational age beyond 16 weeks between 1997 and 2006 were included in this study. The study group consisted of all cases that the patients decided to have second trimester genetic amniocentesis. The control group was a randomized selection of pregnant women who refused any procedures. The ratio of the study case to the control case was 2:1. The fetal loss rates after amniocentesis before 24, and 28 complete weeks and the pregnancy outcome were analyzed.
RESULTS: 2,990 cases in the study group and 1,495 cases in the control group were used for this analysis. The mean maternal age in the study group and control group were 36.89 ± 1.63 and 36.78 ± 1.59 years old, respectively (P = 0.239). The procedure-related fetal loss before 24 and 28 complete weeks were 0.17 and 0.50%, respectively. The most common presenting symptom before fetal loss in the study cases was abdominal pain. Almost all of the cases leading to abortion had symptoms initiated after 48 h post procedure. Significantly higher chances of abortion occurred in pregnant women ≥41 years old (P = 0.008).
CONCLUSION: The procedure-related fetal loss rates in pregnant women ≥35 years old after amniocentesis before 24 and 28 complete weeks were 0.17 and 0.50%, respectively. The certain factors influencing the risk of fetal loss might be independent of the amniocentesis procedure.

Entities:  

Mesh:

Year:  2010        PMID: 21052703     DOI: 10.1007/s00404-010-1727-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  3 in total

1.  An economic analysis of chromosome testing in couples with children who have structural chromosome abnormalities.

Authors:  Kittiphong Thiboonboon; Wantanee Kulpeng; Yot Teerawattananon
Journal:  PLoS One       Date:  2018-06-19       Impact factor: 3.240

2.  Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies.

Authors:  Fuman Jiang; Jinghui Ren; Fang Chen; Yuqiu Zhou; Jiansheng Xie; Shan Dan; Yue Su; Jianhong Xie; Baomin Yin; Wen Su; Huakun Zhang; Wei Wang; Xianghua Chai; Linhua Lin; Hui Guo; Qiyun Li; Peipei Li; Yuying Yuan; Xiaoyu Pan; Yihan Li; Lifu Liu; Huifei Chen; Zhaoling Xuan; Shengpei Chen; Chunlei Zhang; Hongyun Zhang; Zhongming Tian; Zhengyu Zhang; Hui Jiang; Lijian Zhao; Weimou Zheng; Songgang Li; Yingrui Li; Jun Wang; Jian Wang; Xiuqing Zhang
Journal:  BMC Med Genomics       Date:  2012-12-01       Impact factor: 3.063

3.  Ductus Venosus Doppler Flow Velocity after Transplacental and Non-transplacental Amniocentesis during Midtrimester.

Authors:  Burcu Artunc Ulkumen; Halil Gursoy Pala; Yesim Bulbul Baytur; Faik Mumtaz Koyuncu
Journal:  Pak J Med Sci       Date:  2014-09       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.